What Is RSV? Respiratory Syncytial Virus Explained. RSV is one of the most common respiratory infections worldwide. How the virus behaves, how symptoms progress week by week, and which warning signs need rev
RSV, or respiratory syncytial virus, is a common seasonal RNA virus that infects the lining of the nose, throat and small airways. In healthy adults and older children it usually behaves like a heavy cold, with gradual onset over one to three days, a cough that moves into the chest, and recovery within seven to ten days, though the cough can linger for up to three weeks. Infants, adults over sixty-five and people with chronic lung or heart disease carry the highest risk, and reinfection through life is normal because immunity is short-lived.
Respiratory syncytial virus, usually shortened to RSV, is one of the most common causes of respiratory infection worldwide. Most people meet it during early childhood and then again repeatedly through adult life, because infection does not produce lasting immunity. This guide explains what RSV is, how symptoms usually progress, and what recovery normally looks like.
RSV is an enveloped RNA virus that infects the lining of the nose, throat and airways. It gets its name from the way infected cells fuse together into larger multi-nucleated structures, called syncytia, in laboratory conditions.
For healthy older children and adults, RSV often looks like a heavy cold. The pattern tends to follow a recognisable sequence rather than appearing all at once.
RSV is significant less because of how severe it is on average and more because of how many people it reaches. Certain groups carry more of the burden.
Most mild cases are never formally tested, because the result does not change home care. Testing matters when the diagnosis affects treatment, isolation or hospital decisions.
There is no routine antiviral cure for RSV in otherwise healthy people, so care focuses on symptom control and on watching for deterioration.
People managing longer-term breathing symptoms after a viral illness may find this overview of lung health support useful for understanding how ongoing respiratory care is structured. Those interested in how cell-based research intersects with severe viral lung injury can read more about RSV and regenerative research.
Some symptoms suggest the infection has moved beyond a routine upper airway illness and needs assessment the same day.
| Feature | Typical Pattern in RSV |
|---|---|
| Onset | Gradual over one to three days |
| Fever | Often low grade, sometimes absent in older adults |
| Main symptom | Cough with congestion, wheeze in at-risk groups |
| Usual duration | Seven to ten days, cough up to three weeks |
| Reinfection | Common, immunity does not last |
RSV is a common seasonal respiratory infection that most people recover from at home within two weeks, but it carries real risk for infants, older adults and anyone with chronic lung or heart disease, which is why recognising deterioration matters more than identifying the virus itself.
This article is for general informational and educational purposes only and is not a substitute for personalized medical advice. Always consult a qualified healthcare professional before considering stem cell therapy.